Amedeo Smart

Free Medical Literature Service

 

Amedeo

Nuclear Medicine
  Free Subscription

Articles published in
AJNR Am J Neuroradiol
    March 2026
  1. ELMOUJARKACH E, Sharbatdaran A, Pontolillo L, Jean J, et al
    Dynamic Brain [F18]-Fluoroestradiol (FES) PET Protocol Optimization for Improved Detection of Breast Cancer Brain Metastases.
    AJNR Am J Neuroradiol. 2026 Mar 26:ajnr.A9316. doi: 10.3174/ajnr.A9316.
    >> Share

  2. MEI J, Salim HA, Lakhani DA, Balar A, et al
    Gradation of Prolonged Venous Transit on Perfusion Imaging Highlights the Association of Deep Venous Drainage Impairment with Unfavorable Functional Outcome in Successfully Reperfused Anterior Circulation Large-Vessel-Occlusion Stroke.
    AJNR Am J Neuroradiol. 2026;47:604-610.
    >> Share

    February 2026
  3. VU KV, Otis HG, Brandmaier A, Osborne JR, et al
    [68Ga]-DOTATATE PET SUV Reduction After Bevacizumab in High-Grade Meningioma: A Potential Treatment Response Biomarker.
    AJNR Am J Neuroradiol. 2026 Feb 23:ajnr.A9260. doi: 10.3174/ajnr.A9260.
    >> Share

  4. LEE KY, Jeong EH, Lee WW, Song YS, et al
    Classifying Parkinson's Disease Progression via Latent Trajectories of Striatal Specific Binding Ratios from I-123 FP-CIT SPECT in Association with Levodopa-Induced Dyskinesia.
    AJNR Am J Neuroradiol. 2026 Feb 10:ajnr.A9213. doi: 10.3174/ajnr.A9213.
    >> Share

  5. ALIZADA S, Al Qudah H, Debnam JM, Msherghi A, et al
    Multimodal Imaging and Clinicopathologic Features of Parathyroid Lipoadenoma.
    AJNR Am J Neuroradiol. 2026;47:430-436.
    >> Share

  6. DE RUBEIS G, Stasolla A, Piccioli C, Federici M, et al
    The Impact of a Neuroradiologist on the Report of a Real-World CT Perfusion Imaging Map Derived from Artificial Intelligence/Machine Learning-Driven Software.
    AJNR Am J Neuroradiol. 2026;47:336-341.
    >> Share

    January 2026
  7. LUCK S, Sathi N, Shaqra H, Mozayan A, et al
    [Ga68]DOTATATE PET in Schwannomas: Distinct Avidity Pattern Supporting Noninvasive Diagnosis.
    AJNR Am J Neuroradiol. 2026 Jan 30:ajnr.A9183. doi: 10.3174/ajnr.A9183.
    >> Share

  8. FRANCESCHI AM, Peng S, Banegas JI, Keir G, et al
    Utility of [(18)F]PI-2620 as Universal Biomarker for the Amyloid/Tau/Neurodegeneration Classification of Alzheimer Disease: An Exploratory Study with Dual-Phase PET Imaging.
    AJNR Am J Neuroradiol. 2026 Jan 22. doi: 10.3174/ajnr.A8980.
    >> Share

  9. BEJUGAM D, Peck KK, Saha A, Yllera-Contreras E, et al
    Detection of Osseous Spinal Metastasis with T1-Weighted Dynamic Contrast-Enhanced MRI and (18)F-FDG PET/CT: Assessing Agreement in Biopsy Proven Cases.
    AJNR Am J Neuroradiol. 2026 Jan 22:ajnr.A9181. doi: 10.3174/ajnr.A9181.
    >> Share

  10. TU RK, Esposito G, Agarwal A, Akin EA, et al
    ACR-ACNM-ASNR-SNMMI Practice Parameter for the Performance of Brain PET/CT Imaging in Dementia.
    AJNR Am J Neuroradiol. 2026 Jan 8. doi: 10.3174/ajnr.A9105.
    >> Share

  11. FRIEDRICHSEN KA, Judge BA, Jones LA, Rajamanickam J, et al
    Evaluation of [(11)C]CS1P1 in Healthy Young and Older Adults.
    AJNR Am J Neuroradiol. 2026;47:175-183.
    >> Share

    December 2025
  12. IVANIDZE J, Vu KV, Fu R, Brandmaier A, et al
    Clinical Utility of [F18]-Fluciclovine PET/MRI for Differentiating True Progression from Treatment-Related Changes in Patients with Glioblastoma.
    AJNR Am J Neuroradiol. 2025 Dec 1:ajnr.A9120. doi: 10.3174/ajnr.A9120.
    >> Share

    November 2025
  13. FINN Q, Pascual B, Schultz PE, Masdeu JC, et al
    beta-amyloid PET signal reduction in prior ARIA-E regions after anti-amyloid therapy for Alzheimer's disease.
    AJNR Am J Neuroradiol. 2025 Nov 19:ajnr.A9111. doi: 10.3174/ajnr.A9111.
    >> Share

  14. YADAV D, Knight-Greenfield A, Moirano J, Nordvig A, et al
    Amyloid PET Z-score Quantification and correlation with visual semiquantitative grading.
    AJNR Am J Neuroradiol. 2025 Nov 6:ajnr.A9079. doi: 10.3174/ajnr.A9079.
    >> Share

    September 2025
  15. ZHANG S, Lu W, Yao C, Wang J, et al
    (18)F-FDG PET/MR-Based Individual Metabolic Network Analysis for Prognosis Assessment in Temporal and Extratemporal Lobe Refractory Epilepsy.
    AJNR Am J Neuroradiol. 2025 Sep 30:ajnr.A9027. doi: 10.3174/ajnr.A9027.
    >> Share

  16. MIDDLEBROOKS EH, Lin C, Pooley RA, Spangler-Bickell MG, et al
    Feasibility of MR-Guided PET Reconstruction in Detection of Focal Cortical Dysplasia.
    AJNR Am J Neuroradiol. 2025 Sep 27:ajnr.A9023. doi: 10.3174/ajnr.A9023.
    >> Share

  17. MASHRIQI F, Chen M, Keir G, Caravella C, et al
    Hybrid [(18)F] Fluoroestradiol Brain PET/CT/MRI for Detection of Estrogen Receptor-Positive Intracranial Metastases Compared with MRI and Vertex-to-Below the Knees PET Imaging.
    AJNR Am J Neuroradiol. 2025 Sep 18. doi: 10.3174/ajnr.A8863.
    >> Share

  18. VIJAYASHANKAR A, Keir G, Sagnelli M, Petrover D, et al
    Added Value of Amyloid PET Quantification with the Centiloid Scale in Clinical Practice.
    AJNR Am J Neuroradiol. 2025 Sep 18. doi: 10.3174/ajnr.A8850.
    >> Share

    August 2025
  19. HAN Y, Cui Z, Hu W, Cao X, et al
    Similarity of Biological Information Captured by (68)Ga-PSMA-11 PET and ASL Perfusion MRI in Glioblastoma.
    AJNR Am J Neuroradiol. 2025 Aug 21:ajnr.A8965. doi: 10.3174/ajnr.A8965.
    >> Share

  20. KREUTZINGER V, Ziegeler K, Chin CT, Han M, et al
    Foraminal [(18)F]FDG uptake on PET/MRI is associated with radiculopathy and symptom reduction after image-guided nerve root block.
    AJNR Am J Neuroradiol. 2025 Aug 21:ajnr.A8974. doi: 10.3174/ajnr.A8974.
    >> Share

  21. IVANIDZE J, Franceschi AM, Wintermark M, Jordan JE, et al
    ASNR Consensus Statement: Integrating Neuro-PET Interpretation into Neuroradiology Training and Practice.
    AJNR Am J Neuroradiol. 2025 Aug 13:ajnr.A8959. doi: 10.3174/ajnr.A8959.
    >> Share

  22. DAGHER R, Arjmand P, Stevens DA, Wintermark M, et al
    Altered Functional Connectivity and Amyloid Deposition in Posttraumatic Stress Disorder-Associated Cognitive Impairment.
    AJNR Am J Neuroradiol. 2025;46:1660-1669.
    >> Share

    July 2025
  23. SASAKI M, Teraoka Y, Kato A, Nakajima T, et al
    Digital FDG-PET detects MYD88 mutation-driven glycolysis in primary central nervous system lymphoma.
    AJNR Am J Neuroradiol. 2025 Jul 21:ajnr.A8935. doi: 10.3174/ajnr.A8935.
    >> Share

  24. FRANCESCHI AM, Keir G, Benzinger TLS, Cogswell PM, et al
    Clinical Role of Brain PET in Alzheimer Disease in the Era of Disease-Modifying Therapies.
    AJNR Am J Neuroradiol. 2025 Jul 10. doi: 10.3174/ajnr.A8738.
    >> Share

    June 2025
  25. KIM D, Ottesen JA, Kumar A, Ho BC, et al
    Deep Learning-Based Prediction of PET Amyloid Status Using MRI.
    AJNR Am J Neuroradiol. 2025 Jun 27:ajnr.A8899. doi: 10.3174/ajnr.A8899.
    >> Share

  26. SHIBA Y, Aoki K, Ohka F, Deguchi S, et al
    Methionine PET Findings in the Diagnosis of Brain Tumors and Non-Tumorous Mass Lesions: A Single-Center Report on 426 Cases.
    AJNR Am J Neuroradiol. 2025 Jun 12:ajnr.A8871. doi: 10.3174/ajnr.A8871.
    >> Share

  27. DAGHER SA, Learned KO, Dagher R, Wang JR, et al
    [(18)F]-FDG Uptake as a Marker of Residual Anaplastic and Poorly Differentiated Thyroid Carcinoma following BRAF-Targeted Therapy.
    AJNR Am J Neuroradiol. 2025;46:1260-1267.
    >> Share

    May 2025
  28. PAYABVASH S, Sharaf K, Zeevi T, Gross M, et al
    FDG-PET intensity normalization improves radiomics- based survival prediction in oropharyngeal cancer patients: a comparison of the SUV with alternative normalization techniques.
    AJNR Am J Neuroradiol. 2025 May 16:ajnr.A8836. doi: 10.3174/ajnr.A8836.
    >> Share

  29. KONERU M, Mei JY, Lakhani DA, Salim HA, et al
    Prolonged Venous Transit on Perfusion Imaging Is Associated with Longer Lengths of Stay in Acute Large Vessel Occlusions.
    AJNR Am J Neuroradiol. 2025;46:887-891.
    >> Share

  30. SALIM HA, Vagal V, Lakhani DA, Mei J, et al
    Association of Pretreatment Perfusion Imaging Parameters with 90-Day Excellent Functional Outcomes in Anterior Circulation Distal Medium Vessel Occlusion Stroke.
    AJNR Am J Neuroradiol. 2025;46:892-899.
    >> Share

    April 2025
  31. ZHOU C, Kou Y, Zhou W, Zhao W, et al
    Diagnostic Value of PET Tracers in Differentiating Glioma Tumor Recurrence from Treatment-Related Changes: A Systematic Review and Meta-Analysis.
    AJNR Am J Neuroradiol. 2025;46:758-765.
    >> Share

    March 2025
  32. KHALAFI M, Hojjati SH, Wang XH, Zhou L, et al
    Concordance between Centiloid quantification and visual interpretation of amyloid PET scans across the Alzheimer's disease continuum.
    AJNR Am J Neuroradiol. 2025 Mar 18:ajnr.A8743. doi: 10.3174/ajnr.A8743.
    >> Share

  33. YAO C, Hu J, Cui B, Wang J, et al
    Dissociation of Structural and Functional Connectivity and Metabolism in the Neocortex of Idiopathic Generalized Epilepsy: A Simultaneous PET/MRI Multimodal Study.
    AJNR Am J Neuroradiol. 2025 Mar 13. doi: 10.3174/ajnr.A8612.
    >> Share

  34. YEDAVALLI V, Salim HA, Balar A, Lakhani DA, et al
    Hypoperfusion Intensity Ratio Less Than 0.4 Is Associated with Favorable Outcomes in Unsuccessfully Reperfused Acute Ischemic Stroke with Large-Vessel Occlusion.
    AJNR Am J Neuroradiol. 2025;46:483-488.
    >> Share

    February 2025
  35. RICAURTE-FAJARDO A, Franceschi AM, Angelo D, McCalla A, et al
    Implications of Hydrocephalus on [18F]-Fluorodeoxyglucose Positron Emission Tomography Statistical Parametric Mapping Analysis in Neurodegenerative Disease Evaluation.
    AJNR Am J Neuroradiol. 2025 Feb 13:ajnr.A8698. doi: 10.3174/ajnr.A8698.
    >> Share

    January 2025
  36. CAI B, Jiang S, Huang H, Li J, et al
    Fusion of FDG and FMZ PET Reduces False Positive in Predicting Epileptogenic Zone.
    AJNR Am J Neuroradiol. 2025 Jan 10:ajnr.A8647. doi: 10.3174/ajnr.A8647.
    >> Share

    December 2024
  37. ELDAYA RW, Kaya D, Williams M, Calle S, et al
    Clinical and Imaging Features of Head and Neck Metastasis of High-Grade Glioma: A Single Center Case Series.
    AJNR Am J Neuroradiol. 2024 Dec 12. doi: 10.3174/ajnr.A8521.
    >> Share

  38. KEIR G, Roytman M, Mashriqi F, Shahsavarani S, et al
    Atypical Parkinsonian Syndromes: Structural, Functional, and Molecular Imaging Features.
    AJNR Am J Neuroradiol. 2024;45:1865-1877.
    >> Share

    October 2024
  39. MOSSA-BASHA M, Zhu C, Pandhi T, Mendoza S, et al
    Deep Learning Denoising Improves CT Perfusion Image Quality in the Setting of Lower Contrast Dosing: A Feasibility Study.
    AJNR Am J Neuroradiol. 2024;45:1468-1474.
    >> Share

  40. YOU J, Li X, Xia J, Li H, et al
    Hypoperfusion Intensity Ratio and Hemorrhagic Transformation in Patients with Successful Recanalization after Thrombectomy.
    AJNR Am J Neuroradiol. 2024;45:1475-1481.
    >> Share

    September 2024
  41. YING C, Chen Y, Yan Y, Flores S, et al
    Accuracy and longitudinal consistency of PET/MR attenuation correction in amyloid PET imaging amid software and hardware upgrades.
    AJNR Am J Neuroradiol. 2024 Sep 9:ajnr.A8490. doi: 10.3174/ajnr.A8490.
    >> Share

    August 2024
  42. DAGHER R, Arjmand P, Ozkara BB, Radmard M, et al
    Diagnostic Performance of ASL-MRI and FDG-PET in Frontotemporal Dementia: A Systematic Review and Meta-Analysis.
    AJNR Am J Neuroradiol. 2024 Aug 12:ajnr.A8440. doi: 10.3174/ajnr.A8440.
    >> Share

    July 2024
  43. MITCHELLE A, Gorolay VV, Aitken M, Hanneman K, et al
    CTP for the Screening of Vasospasm and Delayed Cerebral Ischemia in Aneurysmal SAH: A Systematic Review and Meta-analysis.
    AJNR Am J Neuroradiol. 2024;45:871-878.
    >> Share

    May 2024
  44. LEE K, Mahmud M, Marx D, Yasen W, et al
    Clinical Arterial Spin-Labeling MR Imaging to Screen for Typical and Atypical Neurodegenerative Disease in the New Era of Alzheimer Treatment.
    AJNR Am J Neuroradiol. 2024;45:632-636.
    >> Share

    April 2024
  45. KEIR G, Mashriqi F, Caravella C, Clouston SAP, et al
    Optimization of [(18)F]-FDOPA Brain PET Acquisition Times for Assessment of Parkinsonism in the Clinical Setting.
    AJNR Am J Neuroradiol. 2024 Apr 25. doi: 10.3174/ajnr.A8207.
    >> Share

  46. KIM JT, Chang SJC, Haghdel A, Ramakrishna RR, et al
    DOTATATE PET/MR Imaging Differentiates Secondary-Progressive from de Novo World Health Organization Grade 3 Meningiomas.
    AJNR Am J Neuroradiol. 2024 Apr 11. doi: 10.3174/ajnr.A8219.
    >> Share

    March 2024
  47. NABAVIZADEH A, Galldiks N, Veronesi M, Lohmann P, et al
    Introducing the American Society of Neuroradiology PET-Guided Diagnosis and Management in Neuro-Oncology Study Group.
    AJNR Am J Neuroradiol. 2024 Mar 28. doi: 10.3174/ajnr.A8243.
    >> Share

  48. RAU A, Reisert M, Taschner CA, Demerath T, et al
    Reducing False-Positives in CT Perfusion Infarct Core Segmentation Using Contralateral Local Normalization.
    AJNR Am J Neuroradiol. 2024;45:277-283.
    >> Share

    February 2024
  49. MUJANOVIC A, Kurmann CC, Manhart M, Piechowiak EI, et al
    Value of Immediate Flat Panel Perfusion Imaging after Endovascular Therapy (AFTERMATH): A Proof of Concept Study.
    AJNR Am J Neuroradiol. 2024;45:163-170.
    >> Share

    December 2023
  50. BEHAR M, Peck KK, Yildirim O, Tisnado J, et al
    T1-Weighted, Dynamic Contrast-Enhanced MR Perfusion Imaging Can Differentiate between Treatment Success and Failure in Spine Metastases Undergoing Radiation Therapy.
    AJNR Am J Neuroradiol. 2023;44:1451-1457.
    >> Share

    October 2023
  51. IVANIDZE J, Nordvig AS, Fajardo AR, Tsiouris AJ, et al
    Medicare Coverage of Amyloid PET: Implications for Clinical Practice.
    AJNR Am J Neuroradiol. 2023 Oct 12. doi: 10.3174/ajnr.A8027.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016